Literature DB >> 1234328

Clinical types and drug therapy of renal impairment in cirrhosis.

J Rodés, J Bosch, V Arroyo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1234328      PMCID： PMC2496268          DOI： 10.1136/pgmj.51.598.492

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  16 in total

1.  THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.

Authors:  W P BALDUS; R N FEICHTER; W H SUMMERSKILL; J C HUNT; K G WAKIM
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

2.  RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. II. FACTORS INFLUENCING MAXIMAL URINARY FLOW RATE.

Authors:  L SHEAR; P W HALL; G J GABUZDA
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

3.  Electrolyte and circulatory changes in terminal liver failure.

Authors:  R HECKER; S SHERLOCK
Journal:  Lancet       Date:  1956-12-01       Impact factor: 79.321

4.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

5.  A rational approach to the hepatorenal syndrome.

Authors:  H O Conn
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

6.  Compartmentalization of ascites and edema in patients with hepatic cirrhosis.

Authors:  L Shear; S Ching; G J Gabuzda
Journal:  N Engl J Med       Date:  1970-06-18       Impact factor: 91.245

7.  [Renal insufficiency caused by diuretics in liver cirrhosis with ascites].

Authors:  J Bosch; V Arroyo; J Rodes; J Teres; J M Bordas; M Bruguera
Journal:  Rev Clin Esp       Date:  1973-12-15       Impact factor: 1.556

8.  Enhancement of renal blood flow by furosemide.

Authors:  J H Ludens; J B Hook; M J Brody; H E Williamson
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

9.  Effects of dopamine on renal function in patients with cirrhosis.

Authors:  D E Barnardo; W P Baldus; F T Maher
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

10.  Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

Authors:  M Epstein; D P Berk; N K Hollenberg; D F Adams; T C Chalmers; H L Abrams; J P Merrill
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965
View more
  9 in total

1.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

2.  Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis.

Authors:  C Clemente; J Bosch; J Rodés; V Arroyo; A Mas; S Maragall
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

3.  Renal failure in hepatic failure.

Authors:  V P Choudhry; M K Bhan
Journal:  Indian J Pediatr       Date:  1980 Nov-Dec       Impact factor: 1.967

Review 4.  Traditional management of liver disorders.

Authors:  M Messner; P Brissot
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  [Hepato-renal syndrome (author's transl)].

Authors:  J Kipnowski; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1981-05-04

Review 6.  Hepatorenal syndrome.

Authors:  Jan Lata
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

7.  Torasemide in the treatment of patients with cirrhosis and ascites.

Authors:  P Gentilini; G Laffi; G La Villa; V Carloni; M Foschi; R G Romanelli; F Marra
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 8.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

9.  Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade.

Authors:  S P Wilkinson; P G Wheeler; M Bernardi; I K Smith; R Williams
Journal:  Postgrad Med J       Date:  1979-12       Impact factor: 2.401
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.